|
ArrayIt Teams with Parkinson's Institute (GenomeWeb News)
NEW YORK (GenomeWeb News) – ArrayIt has inked a collaboration with the Parkinson's Institute to discover biomarkers for Parkinson's disease, the Sunnyvale, Calif.-based firm said today.
(Apr 7, 2009)
Pancreatic cancer biomarkers list created (UPI)
BALTIMORE, April 7 (UPI) -- A Johns Hopkins University scientist has created a compendium of 50,000 possible pancreatic cancer biomarkers and says he's asked his colleagues to study it.
(Apr 7, 2009)
Paired Ends (GenomeWeb News)
Helaman Escobar is leaving his post as the director of the DNA sequencing and genomics core facility at the University of Utah in order to head the DNA sequencing operation at Eurofins' Operon/MWG in Huntsville, Ala. The University of Utah is currently seeking a replacement for his position.
(Apr 7, 2009)
Short Reads (GenomeWeb News)
A new UK genome sequencing center is slated to open soon, the UK's Biotechnology and Biological Sciences Research Council said last week. BBSRC said that the Genome Analysis Centre, located in the Norwich Research Park, will become operational over the next two months and open officially in June.
(Apr 7, 2009)
Helicos Expands Applications for HeliScope as Initial Product Revenues Trickle in (GenomeWeb News)
Over the last few months, Helicos has installed its single-molecule sequencer in at least two institutes.
(Apr 7, 2009)
Pancreatic cancer biomarkers list created (Moldova.org)
A Johns Hopkins University scientist has created a compendium of 50,000 possible pancreatic cancer biomarkers and says he's asked his colleagues to study it.Associate Professor Dr. Akhilesh Pandey, founder and director of the Institute of Bioinformatics in Bangalore, India, said with limited resources available for the testing needed to be considered a bona fide biomarker of clinical value, it's ...
(Apr 7, 2009)
Navigenics Names Jonathan Lord, MD to Serve as President and Chief Executive Officer (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif.----Navigenics, a leading personal genomics testing company, announced today that Jonathan "Jack" T. Lord, MD, has been appointed by the Board of Directors to serve as President and Chief Executive Officer of the firm.
(Apr 7, 2009)
ABI/MDS Launch MALDI MS, Continuing Efforts to Reenergize Their Mass Spec Joint Venture (GenomeWeb News)
Life Technologies' Applied Biosystems and its mass spectrometry joint-venture partner MDS today launched the AB Sciex TOF/TOF 5800 mass spectrometer, the second major launch by the firms in the past six months as they try to turn around a slumping mass-spec operation.
(Apr 7, 2009)
NDCR 2009 Provides First-of-its-Kind Reference for Pharmacists and Healthcare Practitioners (Newswise)
NDCR 2009 by Dr. Daniel A. Hussar provides a first-of-its-kind reference for pharmacists and healthcare practitioners. The book details the 158 drugs that have been marketed in the U.S. during the 2002-2008 period, and features comparisons to previously marketed drugs, specific advantages and disadvantages of each, and ratings for each new drug based on comparisons with related agents.
(Apr 7, 2009)
Lord leaving Humana for CEO job at Navigenics (Louisville Courier-Journal)
Dr. Jonathan Lord, Humana's chief innovation officer, is leaving the Louisville health insurer to be chief executive of a California genomics testing company.
(Apr 7, 2009)
UPI NewsTrack Health and Science News (UPI)
Spitzer looks for prebiotic chemicals ... Pancreatic cancer biomarkers list created ... NASA selects Orion heat shield material ... Fluorescent brain cells may guide surgeons ... Health/Science news from UPI.
(Apr 7, 2009)
Dr. Jonathan Lord leaving Humana to join genomics firm (Business First of Louisville)
Humana Inc.’s senior vice president and chief innovation officer, Dr. Jonathan Lord, will leave the company May 1 to become CEO of a Navigenics Inc. in Foster City, Calif. (HUM)
(Apr 7, 2009)
Infinity Announces Leadership Promotions (dBusinessNews.com)
CAMBRIDGE -- Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced two leadership promotions: John J. Keilty to vice president, information technology and informatics, and Joseph F. McPherson to vice president, facilities and operations.
(Apr 8, 2009)
Poison -- It's What's For Dinner: Hunt Narrows For Genes That Let Packrats Eat Creosote (Science Daily)
As the US Southwest grew warmer from 18,700 to 10,000 years ago, juniper trees vanished from what is now the Mojave Desert, robbing packrats of their favorite food. Now, biologists have narrowed the hunt for detoxification genes that let the rodents eat toxic creosote bushes that replaced juniper. The have identified 24 candidate genes.
(Apr 8, 2009)
This Week in Science (GenomeWeb News)
After eight years at the Howard Hughes Medical Institute, Thomas Cech is stepping down . While Cech led HHMI, its endownment grew by 60 percent and it established its own research campus, Janelia Farm. Cech will be returning to his lab at the University of Colorado, Boulder, to continue his work into telomerase.
(Apr 8, 2009)
Covaris starts DNA shearing service (PharmaBiz)
Covaris Incorporated announced the introduction of DNA shearing service using Covaris instruments and technology.
(Apr 8, 2009)
Town names streets after Terry Pratchett's Discworld books (Guardian Unlimited)
Author visits Somerset town to unveil roads which take their names from his fantasy series If you go down to Wincanton in Somerset today you can wander down Peach Pie Street and Treacle Mine Road, named after Sir Terry Pratchett's fantasy series Discworld. Pratchett visited the town today to unveil the road names at a new housing estate, and was greeted by hundreds of fans – many dressed in ...
(Apr 8, 2009)
SeqWright's Clinical Trial Support Contributes To The Approval Of Two HPV Diagnostic Systems (Medical News Today)
SeqWright Inc., an international leader in the field of contract genomic services, announced today its involvement in Hologic's (formerly Third Wave Technologies) successful clinical trials of two Human Papillomavirus (HPV) in vitro diagnostic tests.
(Apr 8, 2009)
Australia pick Symonds to face Pakistan (Guardian Unlimited)
• Troubled all-rounder returns after counselling • Ponting, Hussey and Johnson rested ahead of Ashes Andrew Symonds has been included in Australia's squad for their limited-overs series against Pakistan, which starts this month. The injured fast bowler Brett Lee and all-rounder Shane Watson have also been recalled but Ricky Ponting, Mike Hussey and Mitchell Johnson have been left out, with a ...
(Apr 8, 2009)
McLaren charged over Hamilton row (Guardian Unlimited)
• Team accused of breaching International Sporting Code • Sacking of sporting director is confirmed McLaren will appear before an extraordinary meeting of the FIA World Motorsport Council in Paris on 29 April to answer charges relating to being in breach of the International Sporting Code, the FIA has confirmed. The summons follows Lewis Hamilton's exclusion from the Australian grand prix for ...
(Apr 8, 2009)
Civil legal aid gap being plugged by private cover, critics warn (Guardian Unlimited)
• 'After the event' insurance funding high-profile cases • Experts say trend may harm access to justice Government plans to rely on private companies funding the cost of civil cases are failing to address the gap in accessing justice, experts say, as pressure on public funding available for civil legal aid continues. Cases being funded by "after the event insurance" (ATE), where insurers cover ...
(Apr 8, 2009)
Scientists Use Advanced Genomic Technology from Applied Biosystems to Uncover Profiles of Gene Activity from Single ... (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Applied Biosystems, a division of Life Technologies Corporation today announced that researchers have discovered comprehensive profiles of gene activity from single cells using the SOLiD™ System, its next-generation genomic analysis platform.
(Apr 8, 2009)
BioInformatics, LLC New Report - Capitalizing On New Opportunities For Stem Cell Products (Medical News Today)
BioInformatics, LLC announces the pending release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March 9, 2009 reversal of the 2001 restrictions on federal funding of human embryonic stem cell research, suppliers of stem cell related products are in need of a fast, accurate assessment of new opportunities in the stem cell products market.
(Apr 8, 2009)
Komen to Fund Cancer PGx Research through New Grants (GenomeWeb News)
NEW YORK (GenomeWeb News) – Susan G. Komen for the Cure, a non-profit organization dedicated to funding breast cancer research and education, has awarded $60 million in grants to US and international researchers, including nearly $19 million to fund research into pharmacogenomics.
(Apr 8, 2009)
SeqWright to Take Stake in LaserGen (GenomeWeb News)
NEW YORK (GenomeWeb News) – SeqWright is set to make an undisclosed equity investment in LaserGen, a Houston-based developer of chemistries for next-generation sequencing applications.
(Apr 8, 2009)
Gen-Probe Completes Tepnel Acquisition (GenomeWeb News)
NEW YORK (GenomeWeb News) – Gen-Probe today said that it has completed its acquisition of Tepnel Life Sciences for £92.8 million (US$136.4 million).
(Apr 8, 2009)
Navigenics names Jonathan Lord CEO (Silicon Valley - San Jose Business Journal)
Personal genomics testing company Navigenics Inc. named Dr. Jonathan Lord president and chief executive.
(Apr 8, 2009)
TRADE NEWS: Agilent Technologies Appoints The Research Institute at Nationwide Children's Hospital as Certified ... (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif., & COLUMBUS, Ohio----Agilent Technologies Inc. today announced that The Research Institute at Nationwide Children's Hospital has achieved Certified Service Provider status for Agilent microarrays.
(Apr 8, 2009)
CLC bio Enjoys Playing the (April) Fool (Bio-IT World)
Bio-IT World | Today's announcement from Danish informatics firm CLC bio that licenses for its flagship Genomics Workbench product were out of stock due to a glitch with a Russian supplier was a successful April's Fool.
(Apr 8, 2009)
Dietrich Stephan Plans Individualized Health Institute in Virginia (Bio-IT World)
Washingon Business Journal| Dietrich Stephan, co-founder of personal genomics company Navigenics, is drawing up plans for a $245-million research institute in Northern Virginia -- the Ignite Institute for Individualized Health.
(Apr 8, 2009)
The Bourne Commendation: Open Access Evangelist Wins 2009 Benjamin Franklin Award (Bio-IT World)
Bio-IT World | Australian open-access evangelist Philip Bourne, a prolific computational biologist at UCSD, journal editor and co-founder of SciVee.tv, has been selected to win the 2009 Benjamin Franklin Award, which will be presented on Tuesday April 28 at the Bio-IT World Expo.
(Apr 8, 2009)
Lordy Me: Navigenics Names Jonathan Lord New CEO (Bio-IT World)
Bio-IT World | Navigenics marked the first anniversary of its personal genomics service by appointing ex-Humana executive Jonathan Lord as its new president and CEO, succeeding Mari Baker.
(Apr 8, 2009)
Women the World Over Rejoice (GenomeWeb News)
A new DNA test from Qiagen outperforms Pap smears in detecting the virus behind cervical cancer, reports the New York Times . An article in the New England Journal of Medicine looks into the effectiveness of human papillomavirus testing versus cytologic testing versus visual inspection of the cervix with acetic acid on of cervical cancer incidence and death in India.
(Apr 8, 2009)
Adding the 'Visual' to the 'Mapper' (GenomeWeb News)
Attila Chordash has been playing around with 23andMe's new Haplogroup Tree Mutation Mapper that is part of the company's new Labs section. Chordash compares the section to Google Labs and at the 23andMe blog they say this section of their service will be "less refined" and "somewhat more fluid."
(Apr 8, 2009)
A New One Steps In (GenomeWeb News)
On its blog, Navigenics has announced that its new president and CEO will be Jonathan Lord . Previously, Lord was the chief innovation officer at Humana in Louisville, and before that he was president of Boston's Health Dialog.
(Apr 8, 2009)
This Week in Genome Research (GenomeWeb News)
In early online edition this week, Canadian scientists used whole genome sequencing on three strains of Streptococcus pneumoniae that had been made resistant to the antibiotic linezolid . Comparative analysis revealed mutations in the 23S rRNA gene in all mutants and at G2576T, a previously recognized resistance mutation.
(Apr 8, 2009)
NSF ... NSFW (GenomeWeb News)
Senators Charles Grassley (R-Iowa) and Barbara Mikulski (D-Md) say in a letter that NSF has not responded adequately to their investigation into NSF employees who viewed pornographic material while at work . According to the New York Times , the allegations involve more than 30 employees and extend over 10 years.
(Apr 8, 2009)
The New Monolith (GenomeWeb News)
Pfizer unveils what the company's structure will look like after it swallows up Wyeth . According to the Wall Street Journal , Pfizer will be splitting its research and development efforts in two: the small molecule section will be overseen by Pfizer's current R&D chief Martin Mackay, and the biologic section will be led by Wyeth's R&D chief Mikael Dolsten.
(Apr 8, 2009)
Infinity Announces Leadership Promotions (dBusinessNews.com)
CAMBRIDGE -- Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced two leadership promotions: John J. Keilty to vice president, information technology and informatics, and Joseph F. McPherson to vice president, facilities and operations.
(Apr 8, 2009)
Young Investigator Profile (GenomeWeb News)
Qian's lab is focused on better understanding cell signaling and discovering diagnostic protein biomarkers for human diseases, such as diabetes, through the development and application of novel mass spectrometry-based proteomics approaches capable of measuring changes in protein abundances and post-translational modifications from mammalian cells, tissues, and biofluids.
(Apr 8, 2009)
Experts Review Cancer Genomics Progress (GenomeWeb News)
Wellcome Trust Sanger Institute Cancer Genome Project members Michael Stratton, Peter Campbell, and Andrew Futreal penned the review, which discuss everything from the general role of somatic mutations in cancer to cancer genome sequencing.
(Apr 8, 2009)
Ohio Hospital Named Agilent CSP for Assays (GenomeWeb News)
NEW YORK (GenomeWeb News) – The Research Institute at Nationwide Children's Hospital has been named a certified service provider for Agilent Technologies' array-based comparative genomic hybridization and gene expression assays on the Agilent platform.
(Apr 8, 2009)
U of Cincinnati Lands $22.7M from NCRR (GenomeWeb News)
NEW YORK (GenomeWeb News) – The University of Cincinnati will use $22.7 million from the National Institutes of Health to start a translational research center that will partner with hospitals in the region to delve into a variety of biomedical science areas including studies that involve proteomics, gene transfer, bioinformatics, imaging, and other applications.
(Apr 8, 2009)
Helicos Appeals European Patent Held by Illumina (GenomeWeb News)
NEW YORK (GenomeWeb News) - Helicos BioSciences has decided to appeal a European Patent Office decision to maintain, in an amended form, a sequencing-related patent owned by Illumina, Helicos said in a filing with the US Securities and Exchange Commission last week.
(Apr 8, 2009)
Canada Grants Millions for 'Omics Research (GenomeWeb News)
NEW YORK (GenomeWeb News) - The Canada Foundation for Innovation has granted C$26 million (US$21.1 million) to a number of institutions and centers to support a broad array of research that includes many biomedical studies involving proteomics, genetics, molecular biology, and biomedical imaging projects.
(Apr 8, 2009)
Nuvera, J&J's Veridex Ink Deal to Develop, Market Breast Cancer Drug Response Dx (GenomeWeb News)
Nuvera Biosciences has penned a licensing agreement with Veridex to develop and commercialize assays to gauge treatment response to tamoxifen and taxane-containing chemotherapies, the companies said this week.
(Apr 8, 2009)
Selling Genomics Services Unit to Beckman, Clinical Data Focuses on Rx, Biomarker Programs (GenomeWeb News)
Clinical Data's sale of its genomic services unit to Beckman Coulter will not affect its pharmacogenomics efforts, but will enable it to better focus on its drug development and biomarker discovery programs, the company said this week.
(Apr 8, 2009)
Investment Bank Reports Advantage of CLIA Labs in Driving Adoption of OncotypeDX (GenomeWeb News)
The US Food and Drug Administration's stalled attempt to regulate complex laboratory-developed genetic tests has helped Genomic Health's Oncotype DX assay to attain dominance in the breast cancer-recurrence screening market, according to a report by investment bank Thomas Weisel Partners.
(Apr 8, 2009)
Scoop!: How two students set up an ice cream business (Independent)
Two years ago Carlo Del Mistro, 27, from Lake Como in northern Italy, was working as a strategist with Lehman Brothers in London – but he didn't see his future in banking. He left to take a full-time MBA at London Business School, where his wife Simone was also doing a one-year Masters in finance course.
(Apr 8, 2009)
NCBS scientists undertake research on cancer pathway based on Hedgehogs protein (PharmaBiz)
Scientists at National Centre for Biological Sciences (NCBS) have discovered a new twist to a crucial signalling pathway, involved in development, based on the protein Hedgehog. This pathway could possibly have an impact on future cancer research.
(Apr 9, 2009)
|
